Manufacturer copay assistance · Monjuvi (J9349) · MorphoSys/Incyte
$0/dose · Maximum benefit Up to $25,000 per calendar year · Covers Monjuvi medication cost only — does not cover administration costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Yes — IncyteCARES Savings Program from MorphoSys/Incyte. Eligible patients may pay as little as $0 out of pocket. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay as little as $0 out of pocket Maximum benefit: Up to $25,000 per calendar year. Covers Monjuvi medication cost only — does not cover administration costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.